These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 26295972)

  • 1. Colorectal cancer models for novel drug discovery.
    Golovko D; Kedrin D; Yilmaz ÖH; Roper J
    Expert Opin Drug Discov; 2015; 10(11):1217-29. PubMed ID: 26295972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the use of 3D colorectal cancer models for novel drug discovery.
    Baião A; Dias S; Soares AF; Pereira CL; Oliveira C; Sarmento B
    Expert Opin Drug Discov; 2022 Jun; 17(6):569-580. PubMed ID: 35343351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Priceless GEMMs: genetically engineered mouse models for colorectal cancer drug development.
    Roper J; Hung KE
    Trends Pharmacol Sci; 2012 Aug; 33(8):449-55. PubMed ID: 22739258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
    Xie BY; Wu AW
    Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of genetically engineered mouse models of colorectal carcinoma to enable translational biology and drug development.
    Roper J; Martin ES; Hung KE
    Curr Protoc Pharmacol; 2014 Jun; 65():14.29.1-10. PubMed ID: 24934606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal models for modeling pancreatic cancer and novel drug discovery.
    Bisht S; Feldmann G
    Expert Opin Drug Discov; 2019 Feb; 14(2):127-142. PubMed ID: 30657339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal models of disease: pre-clinical animal models of cancer and their applications and utility in drug discovery.
    Ruggeri BA; Camp F; Miknyoczki S
    Biochem Pharmacol; 2014 Jan; 87(1):150-61. PubMed ID: 23817077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of natural products in colorectal cancer drug discovery.
    Miura K; Satoh M; Kinouchi M; Yamamoto K; Hasegawa Y; Kakugawa Y; Kawai M; Uchimi K; Aizawa H; Ohnuma S; Kajiwara T; Sakurai H; Fujiya T
    Expert Opin Drug Discov; 2015 Apr; 10(4):411-26. PubMed ID: 25724579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-sensitivity Detection of Micrometastases Generated by GFP Lentivirus-transduced Organoids Cultured from a Patient-derived Colon Tumor.
    Okazawa Y; Mizukoshi K; Koyama Y; Okubo S; Komiyama H; Kojima Y; Goto M; Habu S; Hino O; Sakamoto K; Orimo A
    J Vis Exp; 2018 Jun; (136):. PubMed ID: 29985333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of anti-RON antibody Zt/g4-drug maytansinoid conjugation (Anti-RON ADC) as a novel therapeutics for targeted colorectal cancer therapy.
    Feng L; Yao HP; Wang W; Zhou YQ; Zhou J; Zhang R; Wang MH
    Clin Cancer Res; 2014 Dec; 20(23):6045-58. PubMed ID: 25294907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced Colorectal Cancer Orthotopic Patient-Derived Xenograft Models for Cancer and Stem Cell Research.
    Chicote I; Cámara JA; Palmer HG
    Methods Mol Biol; 2020; 2171():321-329. PubMed ID: 32705653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling Colorectal Cancer Progression Through Orthotopic Implantation of Organoids.
    de Sousa E Melo F; Harnoss JM; Kljavin N; Scott R; Sohn C; Leong KG; de Sauvage FJ
    Methods Mol Biol; 2020; 2171():331-346. PubMed ID: 32705654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-derived xenograft models of colorectal cancer in pre-clinical research: a systematic review.
    Brown KM; Xue A; Mittal A; Samra JS; Smith R; Hugh TJ
    Oncotarget; 2016 Oct; 7(40):66212-66225. PubMed ID: 27517155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse models in squamous cell lung cancer: impact for drug discovery.
    Singh AP; Adrianzen Herrera D; Zhang Y; Perez-Soler R; Cheng H
    Expert Opin Drug Discov; 2018 Apr; 13(4):347-358. PubMed ID: 29394493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug discovery in prostate cancer mouse models.
    Valkenburg KC; Pienta KJ
    Expert Opin Drug Discov; 2015; 10(9):1011-24. PubMed ID: 26027638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse models of colorectal cancer: Past, present and future perspectives.
    Bürtin F; Mullins CS; Linnebacher M
    World J Gastroenterol; 2020 Apr; 26(13):1394-1426. PubMed ID: 32308343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of a potent MEK inhibitor, TAK-733, against colorectal cancer cell lines and patient derived xenografts.
    Lieu CH; Klauck PJ; Henthorn PK; Tentler JJ; Tan AC; Spreafico A; Selby HM; Britt BC; Bagby SM; Arcaroli JJ; Messersmith WA; Pitts TM; Eckhardt SG
    Oncotarget; 2015 Oct; 6(33):34561-72. PubMed ID: 26439693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and characterization of cell lines from chromosomal instable colorectal cancer.
    Maletzki C; Gock M; Randow M; Klar E; Huehns M; Prall F; Linnebacher M
    World J Gastroenterol; 2015 Jan; 21(1):164-76. PubMed ID: 25574089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis.
    Moret R; Hellmers L; Zhang X; Gills J; Hite N; Klinger A; Maresh GA; Canter D; Bardot S; Margolin DA; Li L
    J Vis Exp; 2019 May; (147):. PubMed ID: 31132059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse tumour models to guide drug development and identify resistance mechanisms.
    Das Thakur M; Pryer NK; Singh M
    J Pathol; 2014 Jan; 232(2):103-11. PubMed ID: 24122209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.